Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinical Trial Enrollment

- PMLiVE

ACC and Boehringer develop CME programme in China

Will focus on stroke prevention in atrial fibrillation

Aeterna Zentaris under the cosh as myeloma candidate fails

Phase III trial of perifosine halted after poor results

Shire acquires Swiss biotech Premacure

Gains phase II eye drug for rare infant condition

- PMLiVE

Merck forges on with Vytorin trial after safety review

Won't halt controversial study of its cholesterol drug

- PMLiVE

Letting the patient voice be heard

How well is your campaign really reflecting patient insights – or is it more about what you or their HCPs want them to hear?

- PMLiVE

Pharma CEOs team up to tackle Alzheimer’s

Call for Global Alzheimer’s Action Plan to prevent and treat neurological condition by 2025

- PMLiVE

Suzanne Gagnon joins Idis as CMO

She was formerly chief medical officer at Icon

- PMLiVE

WuXi Pharmatech and OMT expand antibodies agreement

Enables Chinese CRO to increase its service offering

- PMLiVE

MHRA launches virtual ‘innovation office’

Aims to smooth regulatory pathway for companies developing novel medicines, devices or technology

- PMLiVE

Baxter to cut 400 jobs in Puerto Rico

Plans to shift operations to the Dominican Republic

FDA smartphone regulation could stifle innovation

US House Republicans issue warning on guidance and call for more information

- PMLiVE

Havas Health gives Health4Brands new brand identity

Updated identity marks integration of Havas Life London offices

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links